» Articles » PMID: 30740939

Worse Quality of Life, Function, and Pain in Children With Enthesitis, Irrespective of Their Juvenile Arthritis Category

Overview
Specialty Rheumatology
Date 2019 Feb 12
PMID 30740939
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the impact of enthesitis on patient-reported outcomes in children with juvenile idiopathic arthritis (JIA), irrespective of JIA category.

Methods: Children enrolled in the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort were studied. Entheseal tenderness by physician examination in 33 defined locations, Juvenile Arthritis Quality of Life Questionnaire (JAQQ), Quality of My Life (QoML) Questionnaire, Childhood Health Assessment Questionnaire (C-HAQ), and a pain visual analog scale were completed at enrollment, every 6 months for 2 years, and then yearly up to 5 years. Analyses consisted of descriptive statistics, linear mixed models for longitudinal data, and analysis of covariance.

Results: Among 1,371 patients followed for a median of 35.3 months (interquartile range 22.1, 49.2), 214 (16%) had enthesitis, of whom 137 (64%) were classified as having enthesitis-related arthritis. After adjusting for JIA category and covariates, children with enthesitis reported higher JAQQ (mean raw score 2.71 versus 2.16, adjusted difference 0.41 points; 95% confidence interval [95% CI] 0.22, 0.59), higher C-HAQ (0.47 versus 0.31, adjusted difference 0.14 points; 95% CI 0.07, 0.22), higher pain (3.01 versus 1.68, adjusted difference 0.94 points; 95% CI 0.64, 1.25), and lower QoML (7.02 versus 8.23, adjusted difference -0.80 points; 95% CI -1.09, -0.51) scores than children without enthesitis. These differences persisted up to 5 years.

Conclusion: Children with enthesitis, regardless of JIA category, report worse patient-reported outcomes than those without enthesitis. Thus, enthesitis should be assessed in all children with JIA.

Citing Articles

Pediatric Society of the African League Against Rheumatism juvenile idiopathic arthritis recommendations for enthesitis-related arthritis and juvenile psoriatic arthritis.

Hamdi W, Migowa A, Ferjani H, Makhloufi C, Makhlouf Y, Nasef S Clin Rheumatol. 2025; 44(3):901-922.

PMID: 39893309 DOI: 10.1007/s10067-025-07334-x.


Effects of a home-based exercise combined yoga and resistance training in enthesitis-related arthritis in China: study protocol for a randomised controlled trial.

Zhang M, Li J, Su Y, Guo G, Chen N BMJ Open. 2024; 14(2):e078549.

PMID: 38382959 PMC: 10882405. DOI: 10.1136/bmjopen-2023-078549.


Advances in the Diagnosis and Treatment of Enthesitis-Related Arthritis.

Di Gennaro S, Di Matteo G, Stornaiuolo G, Anselmi F, Lastella T, Orlando F Children (Basel). 2023; 10(10).

PMID: 37892310 PMC: 10605472. DOI: 10.3390/children10101647.


Predictors of persisting pain in children with Juvenile Idiopathic Arthritis: a case control study nested in the ReACCh-Out cohort.

McGrath T, Guzman J, Tucker L, Shiff N, Yaskina M, Tupper S Pediatr Rheumatol Online J. 2023; 21(1):102.

PMID: 37715224 PMC: 10504744. DOI: 10.1186/s12969-023-00885-w.


Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial.

Brunner H, Foeldvari I, Alexeeva E, Aktay Ayaz N, Calvo Penades I, Kasapcopur O Ann Rheum Dis. 2022; 82(1):154-160.

PMID: 35961761 PMC: 9811076. DOI: 10.1136/ard-2022-222849.